Kevin K. Barvian

Person

  • Morrisville, NC, US

Patents Grantslast 30 patents

  • Information Patent Grant

    Heterocycle compounds

    • Patent number 7,939,528
    • Issue date May 10, 2011
    • Glaxosmithkline LLC
    • Kevin Karl Barvian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted quinazolinone compounds

    • Patent number 7,625,909
    • Issue date Dec 1, 2009
    • Novartis Vaccines and Diagnostics, Inc.
    • Rustum S. Boyce
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    SUBSTITUTED QUINAZOLINONE COMPOUNDS

    • Publication number 20100105654
    • Publication date Apr 29, 2010
    • Rustum S. BOYCE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL HETEROCYCLE COMPOUNDS

    • Publication number 20090054431
    • Publication date Feb 26, 2009
    • Kevin Karl Barvian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Arylamine mch r1 antagonists

    • Publication number 20070078125
    • Publication date Apr 5, 2007
    • Glaxo Group Limited
    • Kevin K. Barvian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Heterocyclic mchr1 antagoists

    • Publication number 20060194871
    • Publication date Aug 31, 2006
    • Kevin K Barvian
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Substituted quinazolinone compounds

    • Publication number 20050059662
    • Publication date Mar 17, 2005
    • Chiron Corporation
    • Rustum S. Boyce
    • C07 - ORGANIC CHEMISTRY